Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Repare Therapeutics Inc. (RPTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 27,200 options to buy
@ $11.66, valued at
$317.2k
|
|
| 06/12/2023 |
4
| RHOADS ANN D (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 27,200 options to buy
@ $11.66, valued at
$317.2k
|
|
| 06/12/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 27,200 options to buy
@ $11.66, valued at
$317.2k
|
|
| 06/12/2023 |
4
| Molineaux Susan (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 76,200 options to buy
@ $11.66, valued at
$888.5k
|
|
| 06/12/2023 |
4
| Kulkarni Samarth (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 27,200 options to buy
@ $11.66, valued at
$317.2k
|
|
| 06/12/2023 |
4
| Foley Todd (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 27,200 options to buy
@ $11.66, valued at
$317.2k
|
|
| 06/12/2023 |
4
| Civik Thomas (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 27,200 options to buy
@ $11.66, valued at
$317.2k
|
|
| 06/12/2023 |
4
| Bonita David P (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 27,200 options to buy
@ $11.66, valued at
$317.2k
|
|
| 06/09/2023 |
4
| Zinda Michael (EVP, Chief Scientific Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 6,404 shares
@ $12.03, valued at
$77k
Sold 2,869 shares
@ $12.02, valued at
$34.5k
|
|
| 06/07/2023 |
4
| Zinda Michael (EVP, Chief Scientific Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 1,200 shares
@ $12.04, valued at
$14.4k
|
|
| 02/01/2023 |
4
| Zinda Michael (EVP, Chief Scientific Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 24,550 shares
@ $0
Granted 97,100 options to buy
@ $12.42, valued at
$1.2M
|
|
| 02/01/2023 |
4
| Koehler Maria (EVP, Chief Medical Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 26,450 shares
@ $0
Granted 119,250 options to buy
@ $12.42, valued at
$1.5M
|
|
| 02/01/2023 |
4
| Segal Lloyd Mitchell (President and CEO) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 78,550 shares
@ $0
Granted 344,200 options to buy
@ $12.42, valued at
$4.3M
|
|
| 02/01/2023 |
4
| Forte Steve (EVP, CFO) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 24,530 shares
@ $0
Granted 111,050 options to buy
@ $12.42, valued at
$1.4M
|
|
| 01/03/2023 |
4
| Jerel Davis (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Disposed of 287,157 shares
@ $0
Acquired 62,026 shares
@ $0
Disposed of 8,638 shares
@ $0
Acquired 1,866 shares
@ $0
Disposed of 9,561 shares
@ $0
Acquired 2,065 shares
@ $0
Disposed of 65,957 shares
@ $0
Acquired 1,240 shares
@ $0
Disposed of 21,854 shares
@ $0
Acquired 4,721 shares
@ $0
Disposed of 4,721 shares
@ $0 |
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Jerel Davis (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 250,000 shares
@ $16, valued at
$4M
|
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Jerel Davis (10% Owner) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 250,000 shares
@ $12.2517, valued at
$3.1M
Sold 438,795 shares
@ $12.2517, valued at
$5.4M
Sold 13,199 shares
@ $12.2517, valued at
$161.7k
Sold 14,611 shares
@ $12.2517, valued at
$179k
Sold 33,395 shares
@ $12.2517, valued at
$409.1k
Disposed of 614,315 shares
@ $0
Acquired 132,692 shares
@ $0
Disposed of 18,478 shares
@ $0
Acquired 3,992 shares
@ $0
Disposed of 20,454 shares
@ $0
Acquired 4,419 shares
@ $0 |
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Jerel Davis (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 49,000 options to buy
@ $9.55, valued at
$468k
|
|
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2022 |
4
| Zinda Michael (EVP, Chief Science Officer) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Sold 533 shares
@ $11.3, valued at
$6k
|
|
| 01/21/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Bought 577,798 shares
@ $14.1, valued at
$8.1M
Bought 412,264 shares
@ $14.1, valued at
$5.8M
Bought 7,899 shares
@ $14.1, valued at
$111.4k
|
|
| 01/20/2022 |
4
| Forte Steve (EVP, CFO) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Exercised 100,000 options to buy
@ $15.63, valued at
$1.6M
|
|
|
|
|